IPHASE Completes FDA Blood Establishment Registration to Support Biopharma Excellence
IPHASE inodada kuzivisa kupedzwa kwakabudirira kwegore rino FDA Ropa Establishment Registration, ichisimbisa kuzvipira kwedu mukutevedzwa kwemutemo, mhando, uye biopharma - kugadzirira mashandiro.
Pasi pemirairo yeFDA (21 CFR 607), masangano ane chekuita nekugadzirwa kweropa neropa - zvigadzirwa zvakatorwa zvinofanirwa kunyoresa kune agency uye kunyora zvigadzirwa zvinoshanda. This registration confirms that our facility meets FDA requirements for the manufacture and handling of blood and blood-derived products. Kune vadyidzani vebiopharmaceutical, izvi zvinoturikira mukuvimbika mumhando, kuteedzera, uye kusimba kwemaitiro ezvinyorwa zvebiomatrix zvinotsigira tsvakiridzo yepreclinical, kuvandudzwa kweassay, uye pasi pekushandisa.
At IPHASE, compliance is built into every step of our process. Isu tinoramba takazvipira kuunza zvinoenderana, zvakavimbika, uye zvemhando yepamusoro biomatrix mhinduro dzinobatsira zvikwata zvebiopharma kufamba nekukurumidza-kubva mukuwanikwa kuburikidza nebudiriro-apo tichisangana nekuchinja zvinotarisirwa zvinotarisirwa.

Nguva yekutumira: 2026-01-27 16:37:06

